← Open Payments lookup

DOUGLAS MULINIX: Open Payments

NPI 1346284973 · DANVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,918 in 161 payments from 19 companies in 2025. Trend: 2023 $2,916 · 2024 $1,481 · 2025 $2,918

Food & beverage: $2,862Education: $56
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$435
Otsuka America Pharmaceutical, Inc.16$407
Vanda Pharmaceuticals Inc.17$383
Axsome Therapeutics, Inc.13$349
E.R. Squibb & Sons, L.L.C.9$244
Collegium Pharmaceutical, Inc.19$230
Corium, LLC11$165
Supernus Pharmaceuticals, Inc.13$161
Lundbeck LLC6$118
Neurocrine BioSciences, Inc.4$91

Products named: CAPLYTA, HETLIOZ, Auvelity, REXULTI, COBENFY, Jornay PM, ABILIFY ASIMTUFII, Azstarys.

Industry payments across IN — which companies pay providers there.